NCT01274975View on ClinicalTrials.gov

Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury.

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

February 28, 2010

Conditions
Spinal Cord Injury
Interventions
OTHER

Autologous Adipose Derived Mesenchymal Stem Cells

Intravenous infusion of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 4 x 10e8 cells

Sponsors

Lead Sponsor

R-Bio
All Listed Sponsors
lead

R-Bio

INDUSTRY

NCT01274975 - Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury. | Biotech Hunter | Biotech Hunter